Advertisement

ADVERTISEMENT

Sirpa Leppä,

Subcutaneous Epcoritamab Combined With Rituximab + Lenalidomide for the Treatment of Patients with Relapsed or Refractory Follicular Lymphoma: Phase 1/2 Trial Update
Introduction:
11/04/2022

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
ECS
November 8 ⁠–⁠ November 10
WoundCon
November 8
Dermatology Week
November 13 ⁠–⁠ November 16
Psych Congress Primary Care Online Series
November 14 ⁠–⁠ November 15
November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use